• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

    • Radiology
      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

China Mesalazine Market Statistics and Growth Observation, Opportunity Disclosed By New Report 2023-2030 | Novartis AG, Zhejiang Hengkang Pharmaceutical Co. Ltd., F. Hoffmann-La Roche AG

January 19th, 2023 Coherent Market Insights Releases

China Mesalazine Market Analysis:

Mesalazine is an aminosalicylate prescription drug for treating mild to moderate active ulcerative colitis, also keep remission when it has been established. Mesalazine is an anti-inflammatory medication that is structurally linked to non-steroidal anti-inflammatory drugs and salicyclates such as acetylsalicylic acid and is used to treat inflammatory bowel illnesses such as Crohn’s disease and ulcerative colitis. Ulcerative colitis is a chronic inflammatory disease of bowel that involves inflammation of the lining of the large intestine (colon). It causes ulcers on the lining of the colon, which can lead to bleeding and the production of mucus and pus. Mesalazine acts by blocking the formation of certain chemical molecules that cause pain and swelling, such as prostaglandins, which aids in the reduction of swelling and redness of the intestines and gives relief from symptoms such as stomach discomfort or bleeding.

The China mesalazine market is predicted to be worth $51.6 million in 2022, with a CAGR of 3.1% the throughout the predicted period (2022-2030).

Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5371

China Mesalazine Market – Drivers

Growing inorganic initiatives, such as product debuts by prominent market competitors, are likely to propel the China mesalazine market forward. Tillotts Pharma AG, for example, released Asacol 800 mg tablets (mesalazine) as the primary therapy for moderate to mild Ulcerative Colitis (UC) in China in July 2021. It will bring a stronger mesalazine tablet formulation to the Chinese market in order to improve the treatment choices for patients suffering from ulcerative colitis in China.

China Mesalazine Market – Impact of Coronavirus (COVID-19) Pandemic

The illness has spread to over 100 nations after the COVID-19 viral epidemic in December 2019, and the World Health Organization designated it a state medical crisis on January 30, 2020.

The COVID-19 has the potential to impact the economy in three ways: directly impacting medication supply and demand, disrupting distribution networks, and having a financial impact on enterprises and financial markets. Several nations, including the United Arab Emirates, Egypt, Saudi Arabia, India, China and others, are having difficulty transporting pharmaceuticals from one location to another due to national lockdowns.

The COVID-19 epidemic, on the other hand, had a favorable influence on the Chinese mesalazine market. For example, harmed people with Inflammatory Bowel Disease (IBD) both physically and psychologically, according to figures released in 2020 month of May by the National Center for Biotechnology Information. Most IBD patients were sick during the beginning and present periods of the epidemic, and they didn’t have to modify their meds.

China Mesalazine Market: Key Developments

Joint partnerships between industry participants are projected to fuel China mesalazine market expansion throughout the forecast period. For example, in November 2022, Alembic Pharmaceutical Limited, a pharmaceutical firm, reported that it had acquired FDA clearance for the Abbreviated New Drug Application (ANDA) for Mesalazine extended-release capsules of strength 0.375 g.

China Mesalazine Market: Restraint

The availability of mesalazine substitutes is projected to impede the growth of the China mesalazine market during the forecast period. The first-line therapy for ulcerative colitis is aminosalicylate (5-ASA). In addition, several pharmacological classes are approved to treat Chron’s disease, inflammatory bowel disease and ulcerative colitis. Biologic/Biosimilar Therapies, Targeted Synthetic Small Molecules (Immunosuppressants), immunomodulators and Corticosterids and Biologic/Biosimilar Therapies are examples of these drugs (Monoclonal Antibodies). Furthermore, the emergence of biosimilars has transformed the treatment of Ulcerative Colitis (UC). It is a biological therapy for IBD, such as Crohn’s disease and ulcerative colitis. These medicines are much less costly than other medications, making it more accessible to Chinese citizens.

China Mesalazine Market – Key Players

Dr. Falk Pharma Gmbh, Viatris Inc., FERRING B.V., Salix Pharmaceuticals, Norvatis AG, Tillotts Pharma AG, GSK Plc., Takeda Pharmaceuticals Company Limited, Hoffmann-La Roche AG, AbbVie Inc, Ltd., Heilongjiang Tianhong Pharmaceutical Co., Shanghai Pharmaceuticals Holding Co Ltd., ALP Pharm Beijing Co., Ltd., Jiangsu Jubang Pharmaceuticals Co., Ltd., and Zhejiang Hengkang Pharmaceuticals Co. Ltd., is a major participant in the Chinese mesalazine business.

Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5371

Reasons to buy this China Mesalazine Market Report:

✅️ It attempts an analysis of the competing scenario.

✅️ The current and exceptional product revenue market.

✅️ An in-depth data on the regional investigation and competitive landscape structure.

✅️ It benefits in creating an awareness of the important key product segments.

✅️ The marketing strategies, opportunities, and development factors are explained.

✅️ China Mesalazine market size estimation and recent advancements in the industry are explained.

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 China Mesalazine Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: China Mesalazine Industry Impact

Chapter 2 China Mesalazine Competition by Types, Applications, and Top Regions and Countries
2.1 China Mesalazine (Volume and Value) by Type
2.3 China Mesalazine (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 China Mesalazine Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 Company Profiles and Key Figures in China Mesalazine Business
Chapter 6 China Mesalazine Market Forecast (2022-2028)
Chapter 7 Conclusions
Research Methodology

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5371

About US

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email